About Doctoria™
Doctoria™ Ltd is a UK company focused on healthcare and the developer of Ozana AI - real-time interpretation across 80+ languages and ambient clinical documentation. Alongside Ozana AI Scribe and Ozana AI Interpreter, we provide secure digital dictation to the NHS, private providers and emergency services.
Everything we build is GDPR-aligned and runs on a zero-data-storage architecture: no patient audio or transcripts are retained.
Our Commitment to the NHS
We're committed to:
- Supporting NHS long-term plan objectives
- Reducing health inequalities through better communication
- Maintaining the highest data protection standards
- Providing cost-effective solutions for the NHS
- Working closely with NHS staff to improve outcomes
Ready to improve patient communication?
Get in TouchWhy we exist
Clinicians spend hours of every shift on documentation, and millions of UK patients - over 4 million people whose main language is not English - face consultations where critical details are lost in translation. Both problems are communication problems. Doctoria™ exists to remove them from the consultation room, so the time in front of a patient is spent on care, not paperwork or workarounds.
What we do
AI medical scribing
Ozana AI Scribe listens to the consultation and produces a structured, clinician-verified note in seconds - in the language the consultation actually happened in, not just English.
Real-time interpretation
Ozana AI Interpreter delivers voice-to-voice interpretation across 80+ languages, live in the encounter - no phone lines, no scheduling, no delay.
Digital dictation
Secure dictation workflows for GPs, consultants and hospital teams, including cloud dictation built on Philips SpeechLive, with UK-based setup, onboarding and support.
How we handle data
Healthcare technology earns trust through information governance, not marketing. Everything Doctoria™ deploys is GDPR-aligned, designed against the NHS Digital Technology Assessment Criteria (DTAC), and stores no patient data: audio is processed in real time and discarded. Nothing about a patient persists after the encounter ends.
Who we work with
We work with NHS organisations, private clinics and emergency services across the UK, with early deployments and pilots in the UK, the Nordics and the United States. If you are evaluating clinical AI for your organisation, we will demonstrate it live on your own workflows.
Doctoria™ and Ozana AI
Ozana AI is developed by Doctoria™ Ltd in the United Kingdom. Ozana AI Scribe and Ozana AI Interpreter can be ordered online at ozana.ai, and are sold and supported in the United States by Ozana Labs Inc, the group's US entity.
Authority & Recognition
Innovation Programmes
Active participation in healthcare innovation initiatives
NHS Collaborations
Working with NHS organisations on clinical communication
Academic Collaborations
Research partnerships with leading universities
Accelerator Alumni
Recognised by healthcare technology accelerators
Grants & Funding
Doctoria™'s clinical communication research has been supported by nationally and internationally recognised funding bodies.
Innovate UK
Awarded competitive grant funding from Innovate UK to develop and advance clinical communication technology for the NHS and regulated healthcare environments.
European Union Funding
Supported by EU funding programmes for healthcare innovation, enabling cross-border research in health equity and secure multilingual communication.
Company Updates
September 2026
Ozana AI Interpreter and Ozana AI Scribe launched for beta testing
Both products entered beta with NHS and private clinicians, bringing ambient documentation and real-time interpretation into live clinical workflows.
January 2026
AI Scribe Enters Waiting List Phase
Healthcare professionals across the UK can now join the waiting list for early access to Doctoria™'s AI-powered clinical documentation tool.
September 2025
Horizon Europe Grant Awarded
Won EU Horizon Europe grant funding for healthcare innovation and cross-border health equity initiatives. Admitted into Propel Scale Up Programme.
2025
Landed in the US
Doctoria™ expands to the US East Coast, establishing presence at Fairfax Mason Enterprise Center, Virginia.
2025
Partnerships & Clinical Testing
Partnership with Bradford University and the Nordic Access Network. Readiness certificate issued to test with Hospitals in the Nordics. Testing started with Fire Departments in the US.
2025
Barclays Eagle Lab & Philips Partnership
Admitted into Barclays Eagle Lab Investability Program. Signed an authorised partnership with Philips to resell their SpeechLive digital dictation solution.
2025
NHS Assurance Readiness
Preparing for HIPAA, GDPR & DTAC NHS Assurance, aligning Doctoria™ with NHS digital frameworks for compliant deployment.
2025
Doctoria™ Joins The Innovation Pop Up
Doctoria™ establishes a presence at The Innovation Pop Up at Leeds Teaching Hospital, embedding within the NHS innovation ecosystem.
2023
Accepted into Accelerator Programmes
Joined Innovate UK Investability, Yorkshire and Humber Propel Accelerator, and received mentorship from the UK AHSN Leeds.
November 2022
Innovate UK Grant Awarded
Won a £50,000 Innovate UK grant to build the MVP. Initial research conducted with real patients and doctors. Trademark registered in the UK.
2021
Company Established in the UK
Doctoria™ Ltd founded in the United Kingdom, beginning the mission to build clinical communication infrastructure for safety-critical healthcare environments.